More on CELG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CELG Income Statement

Click line-items for a historical chart and %
Revenue:
Net product sales 1.72B
Collaborative agreements and other revenue 2.3M
Royalty revenue 28.7M
Total revenue 1.76B
Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 731.2M
Selling, general and administrative 448.7M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net 91.7M
Total costs and expenses 1.43B
Operating income 325.8M
Other income and expense:
Interest and investment income, net 7.4M
Equity in (gains) losses of affiliated companies
Interest expense -30.1M
Other income, net -85.9M
Income before income taxes 217.2M
Income tax provision 2.8M
Net income 214.4M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 0.53
Diluted 0.5
Weighted average shares:
Basic -830.5M
Diluted -860M